BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18474601)

  • 1. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
    Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
    J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.
    Kumar KG; Barriere H; Carbone CJ; Liu J; Swaminathan G; Xu P; Li Y; Baker DP; Peng J; Lukacs GL; Fuchs SY
    J Cell Biol; 2007 Dec; 179(5):935-50. PubMed ID: 18056411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
    Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
    J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent pathway that controls stability of interferon alpha receptor.
    Liu J; Plotnikov A; Banerjee A; Suresh Kumar KG; Ragimbeau J; Marijanovic Z; Baker DP; Pellegrini S; Fuchs SY
    Biochem Biophys Res Commun; 2008 Mar; 367(2):388-93. PubMed ID: 18166147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
    Kumar KG; Krolewski JJ; Fuchs SY
    J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies.
    Carbone CJ; Zheng H; Bhattacharya S; Lewis JR; Reiter AM; Henthorn P; Zhang ZY; Baker DP; Ukkiramapandian R; Bence KK; Fuchs SY
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19226-31. PubMed ID: 23129613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
    Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
    Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
    Ragimbeau J; Dondi E; Alcover A; Eid P; Uzé G; Pellegrini S
    EMBO J; 2003 Feb; 22(3):537-47. PubMed ID: 12554654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.
    Cho IR; Oh M; Koh SS; Malilas W; Srisuttee R; Jhun BH; Pellegrini S; Fuchs SY; Chung YH
    Int J Mol Med; 2012 Apr; 29(4):581-6. PubMed ID: 22218495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
    Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
    Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
    Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
    Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.
    Akbari M; Akhavan-Bahabadi M; Shafigh N; Taheriazam A; Hussen BM; Sayad A; Fathi M; Taheri M; Ghafouri-Fard S; Fathi M
    Cytokine; 2022 May; 153():155849. PubMed ID: 35339044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
    Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
    Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
    Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
    J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; HuangFu WC; Liu J; Veeranki S; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2010 Jan; 285(4):2318-25. PubMed ID: 19948722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.
    Zheng H; Qian J; Baker DP; Fuchs SY
    J Biol Chem; 2011 Oct; 286(41):35733-35741. PubMed ID: 21865166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
    Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction.
    Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H
    Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.